ComplyRx

Immunology & inflammation · Live ClinicalTrials.gov data

Upadacitinib (Rinvoq) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 upadacitinib (Rinvoq) trials on ClinicalTrials.gov by enrolment, 1 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

11

Phase 3 trials

1

Actively recruiting

Dec 2026

Next phase 3 primary completion

8,599

Participants across trials

AbbVie

Lead sponsor by trial count

upadacitinib (16)4 active2013–2029
upadacitinib
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompleted
'13
'15
'17
'19
'21
'23
'25
'27
'29
upadacitinib
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyP2
BALANCE-EXTENDP2
SELECT-NEXTP3
SELECT-EARLYP3
A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic DermatitisP2
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic TherapyP3
A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)P3
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)P3
Rising UpP3
SELECT-GCAP3
COVERP4
Level UpP3
Viti-UpP3
VICTRIVAP3
Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled StudyP3
UP-FOR-UP4

Upcoming readouts

4 ahead · upadacitinib

Select a trial to load its full ClinicalTrials.gov record.

Key upadacitinib trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07018206UP-FOR-U: Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axi…Phase 4Not yet recruitingMay 2027
NCT05080218COVER: COVID-19 VaccinE Response in Rheumatology PatientsPhase 4CompletedApr 2024
NCT06227910VICTRIVA: A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseasePhase 3RecruitingJun 2027
NCT07149467Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory C…Phase 3Not yet recruitingDec 2026
NCT06118411Viti-Up: A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Ado…Phase 3Active, not recruitingMar 2028
NCT02675426SELECT-NEXT: A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Sta…Phase 3CompletedApr 2017
NCT02706873SELECT-EARLY: A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adult…Phase 3CompletedMar 2018
NCT02955212A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderatel…Phase 3CompletedAug 2019
NCT03607422A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermat…Phase 3CompletedMar 2021
NCT03345836A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to …Phase 3CompletedAug 2021
NCT03661138Rising Up: A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adoles…Phase 3CompletedAug 2022
NCT03725202SELECT-GCA: A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arte…Phase 3CompletedFeb 2024

Track upadacitinib with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track upadacitinib

Related drug pipelines

Compare upadacitinib vs dupilumabCompare upadacitinib vs lebrikizumab

FAQ

How many clinical trials are running for upadacitinib?
ClinicalTrials.gov lists more than 16 phase 2–4 upadacitinib trials. This page tracks the 16 largest by enrolment: 3 phase 2, 11 phase 3, and 2 phase 4 among them, with 1 actively recruiting. Updated daily.
Are there clinical trials for Rinvoq?
Rinvoq is the brand name for upadacitinib, so upadacitinib trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 upadacitinib trials. This page tracks the 16 largest by enrolment: 3 phase 2, 11 phase 3, and 2 phase 4 among them, with 1 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare upadacitinib against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.